Despite the increasing burden of rheumatic diseases on the US population, there is a national shortage of rheumatology investigators in major medical centers working to find the causes and cures of these debilitating disorders. The Rheumatology Training Program at the University of Washington (UW) is designed to help address this important shortfall and has a long-standing track record of success. The UW attracts highly qualified trainees both from within the residency program and nationally that are motivated to help fill this urgent need. The goal of our combined adult and pediatric training program is to provide MD and PhD postdoctoral fellows high quality basic or clinical science training in rheumatic disease and to equip them to become independent academic researchers. Several major changes to our training program were instituted during the last funding period we have: 1) created 3 pathways -basic, clinical and translational to accommodate the needs, interests and skills of both the applicant pool and mentors in the program; 2) linked the program to access to a number of robust biorepositories to facilitate translational research; 3) consolidated our pool of outstanding established mentors and recruited a significant number of new mentors and co-mentors to facilitate training in new pathways; 4) recruited new faculty to both adult and pediatric rheumatology divisions; 5) promoted our mentors-in-training to mentors in the program; and 5) increased the number of ACGME fellowship positions. The proposed training for this competitive renewal requests 5 postdoctoral fellowship positions. In addition, based on the need to attract medical students to the exciting field of rheumatology and previous success in recruiting medical students into our fellowship training program, we are requesting two annual short-term summer electives for medical students. The fellowship program is open to MDs who have completed a clinical year in Rheumatology and PhDs who have completed their accredited training. MDs in the clinical pathway are required to enter the Masters or Certificate Program in epidemiology or public health at the UW School of Public Health. Our typical trainee completes three years of basic and clinical science training during which time all trainees are expected to publish their work and submit a fellowship(s) grant. A formal mentoring program that assists trainees with career and scientific guidance, and a well- designed core curriculum, provides all trainees with essential skills in grant writing and other assets required for long-term success. Finally, two committees (Selection & Advisory and External Advisory) assist the joint Program Directors in programmatic governance, and to ensure the programmatic benchmarks and expectations are achieved.

Public Health Relevance

Arthritis and other rheumatic diseases are major unmet medical needs, through high-quality mentoring in a broad-based and interactive research environment, this T32 program will support the training of outstanding MD and PhD investigators.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Institutional National Research Service Award (T32)
Project #
5T32AR007108-38
Application #
9302277
Study Section
Arthritis and Musculoskeletal and Skin Diseases Special Grants Review Committee (AMS)
Program Officer
Mancini, Marie
Project Start
1975-07-01
Project End
2020-06-30
Budget Start
2017-07-01
Budget End
2018-06-30
Support Year
38
Fiscal Year
2017
Total Cost
Indirect Cost
Name
University of Washington
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Dam, Elizabeth M; Maier, Alison C; Hocking, Anne M et al. (2018) Increased Binding of Specificity Protein 1 to the IL21R Promoter in B Cells Results in Enhanced B Cell Responses in Rheumatoid Arthritis. Front Immunol 9:1978
Gorman, Jacquelyn A; Hundhausen, Christian; Errett, John S et al. (2017) The A946T variant of the RNA sensor IFIH1 mediates an interferon program that limits viral infection but increases the risk for autoimmunity. Nat Immunol 18:744-752
Sontheimer, Clayton; Liggitt, Denny; Elkon, Keith B (2017) Ultraviolet B Irradiation Causes Stimulator of Interferon Genes-Dependent Production of Protective Type I Interferon in Mouse Skin by Recruited Inflammatory Monocytes. Arthritis Rheumatol 69:826-836
Jackson, Shaun W; Jacobs, Holly M; Arkatkar, Tanvi et al. (2016) B cell IFN-? receptor signaling promotes autoimmune germinal centers via cell-intrinsic induction of BCL-6. J Exp Med 213:733-50
Gazitt, Tal; Lood, Christian; Elkon, Keith B (2016) Citrullination in Rheumatoid Arthritis-A Process Promoted by Neutrophil Lysis? Rambam Maimonides Med J 7:
Buechler, Matthew B; Akilesh, Holly M; Hamerman, Jessica A (2016) Cutting Edge: Direct Sensing of TLR7 Ligands and Type I IFN by the Common Myeloid Progenitor Promotes mTOR/PI3K-Dependent Emergency Myelopoiesis. J Immunol 197:2577-82
Dam, Elizabeth M; Habib, Tania; Chen, Janice et al. (2016) The BANK1 SLE-risk variants are associated with alterations in peripheral B cell signaling and development in humans. Clin Immunol 173:171-180
Shenoi, Susan; Bell, Samantha; Wallace, Carol A et al. (2015) Juvenile idiopathic arthritis in relation to maternal prenatal smoking. Arthritis Care Res (Hoboken) 67:725-30
Lin, Phoebe; Bach, Mary; Asquith, Mark et al. (2014) HLA-B27 and human ?2-microglobulin affect the gut microbiota of transgenic rats. PLoS One 9:e105684
Elkon, Keith B; Sontheimer, Clayton (2014) Editorial: toll-like receptor 7: more than skin deep? Arthritis Rheumatol 66:481-4

Showing the most recent 10 out of 49 publications